118679-18-8Relevant articles and documents
TRIAZOLE DERIVATIVES USEFUL AS AXL INHIBITORS
-
Page/Page column 168, (2010/11/26)
Triazole derivatives and pharmaceutical compositions containing the derivatives are disclosed as being useful in inhibiting the activity of the receptor protein tyrosine kinase Axl. Methods of using the derivatives in treating diseases or conditions associated with Axl catalytic activity are also disclosed.
Sulfonamide anti-arrhythmic agents
-
, (2008/06/13)
A series of novel N-alkyl-N-(alkanesulphonamidoheterocyclicmethyl)-4-alkanesulphonamidophenetyl mines have been prepared, including their pharmaceutically acceptable salts and various key novel intermediates therefor. The heterocyclic moiety present in these compounds is a benzo-fused heterocyclic group derived from either benzofuran, benzothiophene, benzoxazole or quinoline, and it is attached to the adjacent methyl group of the molecule by means of the available ring carbon atom which is situated alpha to the hetero atom. These particular compounds are useful in therapy as highly effective anti-arrhythmic agents and therefore, are of value in the treatment of various cardiac arrhythmias. Preferred member compounds include N-methyl-N-(5-methanesulphonamidobenzofur-2-ylmethyl)-4-methanesulphonamidop henethylamine and N-methyl-N-(6-methanesulphonamidoquinol-2-ylmethyl)-4-methanesulphonamidophen thylamine. Methods for preparing all these compounds from known starting materials are provided.
Benzazepine antiarrhythmic agents
-
, (2008/06/13)
Compounds of the formula: STR1 or a salt thereof, wherein "Het" is a group of the formula: STR2 in which R1 is attached to position "a" or "b" of the benzene ring and R and R1, which are the same, are --NHSO2 (C1/sub
